Results for 'patient outcomes'
MSL Talk: Tom Caravela
AI in Medical Affairs
AI in Medical Affairs, patient outcomes, predictive analytics, rare disease identification, prompt engineering
In this episode, Tom Caravela and Patrina Pellett discuss insights from a recent AI in Medical Affairs conference. Tom highlights the lively atmosphere and key AI topics like efficiencies, patient outcomes, and use cases. The conversation covers AI's role in content development, training, predictive…
Feb 4th • 33 mins listen
Rebecca Previs
Empowering Breast Cancer Patients: Biomarker Breakthroughs & Self-Advocacy
Rebecca Previs, Suzanne Garner, breast cancer, digital, biomarker, genetic testing, advocacy
Suzanne Garner’s journey shows how education, advocacy, and technology are reshaping breast cancer patient care and clinical trial access.
Oct 19th • 26 mins listen
The Oncology Nursing Podcast
Biomarker Testing Improves Outcomes for Patients With Non-Small Cell Lung Cancer
ONS member Beth Sandy, MSN, CRNP, thoracic oncology nurse practitioner at the University of Pennsylvania Abramson Cancer Center in Philadelphia, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss key considerations for oncology nurses regarding biomarker testing for …
May 24th • 34 mins listen
Kirk Shepard
The Power of Commercial Leadership in Oncology
Discover how commercial leadership, collaboration, and clear communication shape success in oncology—and why patients depend on it.
Mar 17th • 31 mins listen
Monty Pal
Expanding the Reach of TIL Therapy: What Will it Take?
City of Hope, Monty Pal, Kelly Mahuron, TIL, tumor-infiltrating lymphocyte, melanoma, oncolytic virus, pancreatic cancer, colorectal tumor, immunotherapyn
Dr. Mahuron shares how tumor-infiltrating lymphocyte (TIL) therapy is evolving to reach more patients and improve cancer outcomes.
Aug 4th • 38 mins listen
Rebecca Previs
Why Genetic Testing Should Be Standard in Prostate Cancer
Labcorp, Rebecca Previs, Sarah Young, genetic counselor, genetic testing, prostate cancer, urologic oncology, germline, somatic, PARP inhibitors, digital
Hear why universal genetic testing matters in prostate cancer — plus, how it can improve treatment, equity, and outcomes for patients everywhere.
May 18th • 19 mins listen
Rebecca Previs
Why Comprehensive Testing Matters - Ken Schlosser’s Lung Cancer Story
Labcorp, Rebecca Previs, Ken Schlosser, biomarker, lung cancer, ALK+, advocacy, precision
Biomarker testing helped Ken Schlosser live with stage IV lung cancer for over 6 years. Here's how it shaped his care plan from the start.
Jul 31st • 23 mins listen
Rebecca Previs
Redefining Ovarian Cancer Care with Biomarkers
Labcorp, Rebecca Previs, Kyle Strickland, ovarian cancer, diagnosis, biomarker, HRD, RB1, tumor biology
Exploring ovarian cancer, biomarkers HRD & RB1, and how Labcorp innovations are advancing precision oncology.
Sep 7th • 14 mins listen
Monty Pal
Movement as Medicine: The Science Reshaping Oncology
City of Hope, Monty Pal, Lee Jones, movement, exercise, holistic
In this episode of "On the Edge of Breakthrough: Voices of Cancer Research," host Dr. Monty Pal welcomes Dr. Lee Jones, Head of the Exercise Oncology Program in the Department of Medicine at City of Hope, to discuss how exercise science is helping reshape cancer treatment and care. Dr. Jones shares …
Oct 27th • 56 mins listen
Monty Pal
Asking the Impossible: How Bold Questions are Unlocking Diabetes Biggest Breakthroughs
City of Hope, Monty Pal, Alberto Pugliese, diabetes, microbiome, pancreas
In this episode of On the Edge of Breakthrough: Voices of Cancer Research, Dr. Monty Pal sits down with Dr. Alberto Pugliese, Samuel Rahbar Chair in Diabetes & Drug Discovery, chair of the Department of Diabetes Immunology and director of The Wanek Family Project for Type 1 Diabetes. Tune in to disc…
Nov 10th • 51 mins listen
Kirk Shepard
How Cross-Functional Teams Reshape Cancer Care
Jay Fine, Preclinical Research, Early Stage
In episode 3 of Oncology Voice Network Podcast, Dr. Kirk Shepard sits down with Dr. Jay Fine, a renowned immunologist and President of R&D at Evolve Immune Therapeutics and a Forbes-published author in Voices of Oncology, for a candid look at how discovery truly connects to patient care.
Feb 17th • 23 mins listen
Monty Pal
How Mentorship Sparks Innovation: A Conversation with Dr. Wesley Yip
City of Hope, Monty Pal, Wesley Yip, urological oncology, microbiome, mentor
In the season 3 finale episode of On the Edge of Breakthrough: Voices of Cancer Research, Dr. Monty Pal welcomes Wesley Yip, M.D., Assistant Professor, Division of Urology and Urologic Oncology, Department of Surgery at City of Hope. The duo explores Dr. Yip’s career journey sparked by an early i…
Jan 6th • 35 mins listen
Michael Pietrack
ASPIRING MSL INSIGHTS - Why is the MSL Role so Popular?
ASPIRING MSL INSIGHTS - Why is the MSL Role so Popular? If you’re considering a career as a Medical Science Liaison, you have certainly stumbled on something special. But did you know it is the most highly coveted role in Pharma? That is why it is so hard to break in. There’s so mu…
Nov 25th • 4 mins listen
Michael Pietrack
Season 1, Episode 23: Revolutionizing Cancer Treatment with Paul Romness
Welcome back to the Pharmaverse, where we speak to the greatest voices in Pharma, to learn from their leadership and incredible careers! In this episode of the Pharmaverse podcast, host Michael Pietrack interviews Paul Romness, CEO of OS Therapies. The conversation delves into the inspiring sto…
Nov 18th • 25 mins listen
Asco Daily News Podcast
Addressing the Impact of Prior Authorization on Access to Cancer Treatment
Drs. Nathan Pennell and Nancy Lin discuss emerging data on the growing problem of prior authorization and insurance denials in cancer care, their potentially harmful impact on patient outcomes, and what can be done to fix the problem.
Jun 8th • 26 mins listen